CYCLE-1
Heart FailureThis trial will test whether adding in tovinontrine (a medication) to standard of care medications for heart failure will reduce the chances of being hospitalized for heart failure or dying from heart disease.
null
Participation Requirements
-
Sex:
Any -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
Patients with a diagnosis of heart failure, and a reduced ejection fraction ("EF") of less than 40%.
Exclusion Criteria:
Quite a few related to patient safety or medication interactions.
Study Location
University of Alberta
University of AlbertaEdmonton, Alberta
Canada
Contact Study Team
- Study Sponsored By
- University of Alberta
- Participants Required
- More Information
- Study ID:
Pro00140660